These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2158024)

  • 1. Chronic morphine exposure blocks opioid effects on both the early and late inhibitory postsynaptic potentials in hippocampal CA1 pyramidal cells.
    Wimpey TL; Caudle RM; Chavkin C
    Neurosci Lett; 1990 Mar; 110(3):349-55. PubMed ID: 2158024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mu opioid receptor activation reduces inhibitory postsynaptic potentials in hippocampal CA3 pyramidal cells of rat and guinea pig.
    Caudle RM; Chavkin C
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1361-9. PubMed ID: 1969476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mu opioid receptors participate in the excitatory effect of opiates in the hippocampal slice.
    Bostock E; Dingledine R; Xu G; Chang KJ
    J Pharmacol Exp Ther; 1984 Dec; 231(3):512-7. PubMed ID: 6094789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphine and opioid peptides reduce inhibitory synaptic potentials in hippocampal pyramidal cells in vitro without alteration of membrane potential.
    Siggins GR; Zieglgänsberger W
    Proc Natl Acad Sci U S A; 1981 Aug; 78(8):5235-9. PubMed ID: 6272296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of chronic morphine administration on the mu and delta opioid responses in the CA1 region of the rat hippocampus.
    Wimpey TL; Opheim KE; Chavkin C
    J Pharmacol Exp Ther; 1989 Nov; 251(2):405-11. PubMed ID: 2553917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of opioid and GABA receptor control of excitability and membrane conductance in hippocampal CA1 pyramidal cells in rat.
    Swearengen E; Chavkin C
    Neuropharmacology; 1989 Jul; 28(7):689-97. PubMed ID: 2569690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mu opioid receptor-mediated modulation of synaptic currents in dentate granule cells of rat hippocampus.
    Xie CW; Morrisett RA; Lewis DV
    J Neurophysiol; 1992 Oct; 68(4):1113-20. PubMed ID: 1359026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrahippocampal injections of a specific mu-receptor ligand PL017 produce generalized convulsions in rats.
    Lee PH; Obie J; Hong JS
    Brain Res; 1988 Feb; 441(1-2):381-5. PubMed ID: 2834004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventral hippocampal dentate granule cell lesions enhance motor seizures but reduce wet dog shakes induced by mu opioid receptor agonist.
    Lee PH; Hong JS
    Neuroscience; 1990; 35(1):71-7. PubMed ID: 2163033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide opioid antagonist separates peripheral and central opioid antitransit effects.
    Shook JE; Pelton JT; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1987 Nov; 243(2):492-500. PubMed ID: 2824748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous intrathecal opioid analgesia: tolerance and cross-tolerance of mu and delta spinal opioid receptors.
    Russell RD; Leslie JB; Su YF; Watkins WD; Chang KJ
    J Pharmacol Exp Ther; 1987 Jan; 240(1):150-8. PubMed ID: 3027302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid-induced epileptiform bursting in hippocampal slices: higher susceptibility in ventral than dorsal hippocampus.
    Lee PH; Xie CW; Lewis DV; Wilson WA; Mitchell CL; Hong JS
    J Pharmacol Exp Ther; 1990 May; 253(2):545-51. PubMed ID: 2159997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid pharmacology in the rat hippocampal slice.
    Valentino RJ; Bostock E; Dingledine R
    Life Sci; 1982 Nov 15-22; 31(20-21):2339-42. PubMed ID: 6131361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous intrathecal opioid treatment abolishes the regulatory effects of magnesium and guanine nucleotides on mu opioid receptor binding in rat spinal membranes.
    Wong CS; Su YF; Watkins WD; Chang KJ
    J Pharmacol Exp Ther; 1992 Jul; 262(1):317-26. PubMed ID: 1320689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of morphine and naloxone on hippocampal CA3 field potentials following systemic administration in the freely-moving rat.
    Linseman MA; Corrigall WA
    Brain Res Bull; 1984 Aug; 13(2):241-5. PubMed ID: 6093941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociation of mu and delta opioid receptor-mediated reductions in evoked and spontaneous synaptic inhibition in the rat hippocampus in vitro.
    Lupica CR; Proctor WR; Dunwiddie TV
    Brain Res; 1992 Oct; 593(2):226-38. PubMed ID: 1360320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological actions of delta opioids in CA1 of the rat hippocampal slice are mediated by one delta receptor subtype.
    Watson GB; Lanthorn TH
    Brain Res; 1993 Jan; 601(1-2):129-35. PubMed ID: 8381696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective inactivation of opioid receptors in rat hippocampus demonstrates that dynorphin-A and -B may act on mu-receptors in the CA1 region.
    Chavkin C; Henriksen SJ; Siggins GR; Bloom FE
    Brain Res; 1985 Apr; 331(2):366-70. PubMed ID: 2859095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociation of mu opioid tolerance from receptor down-regulation in rat spinal cord.
    Nishino K; Su YF; Wong CS; Watkins WD; Chang KJ
    J Pharmacol Exp Ther; 1990 Apr; 253(1):67-72. PubMed ID: 2158554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperpolarizing synaptic potentials evoked in CA1 pyramidal cells by glutamate stimulation of interneurons from the oriens/alveus border of rat hippocampal slices. II. Sensitivity to GABA antagonists.
    Samulack DD; Lacaille JC
    Hippocampus; 1993 Jul; 3(3):345-58. PubMed ID: 8102583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.